These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15775358)

  • 1. [History of the development of new vitamin D analogs for the treatment of renal failure, and future aspects].
    Nishii Y
    Clin Calcium; 2002 Jun; 12(6):730-6. PubMed ID: 15775358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. History of the development of new vitamin D analogs: studies on 22-oxacalcitriol (OCT) and 2beta-(3-hydroxypropoxy)calcitriol (ED-71).
    Nishii Y; Okano T
    Steroids; 2001; 66(3-5):137-46. PubMed ID: 11179721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D analogs: therapeutic applications and mechanisms for selectivity.
    Brown AJ; Slatopolsky E
    Mol Aspects Med; 2008 Dec; 29(6):433-52. PubMed ID: 18554710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice.
    Wietrzyk J; Nevozhay D; Filip B; Milczarek M; Kutner A
    Anticancer Res; 2007; 27(5A):3387-98. PubMed ID: 17970085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent progress of study on vitamin D analogs].
    Kittaka A; Saito N; Takano M
    Clin Calcium; 2006 Jul; 16(7):1154-65. PubMed ID: 16816476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.
    Brown AJ; Slatopolsky E
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):134-44. PubMed ID: 17237840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model.
    Wietrzyk J; Nevozhay D; Milczarek M; Filip B; Kutner A
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):787-97. PubMed ID: 18188568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress in research on vitamin D analogs].
    Kubodera N
    Clin Calcium; 2006 Jul; 16(7):1167-72. PubMed ID: 16816477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-osteoclastogenic action of active vitamin D.
    Takasu H
    Nutr Rev; 2008 Oct; 66(10 Suppl 2):S113-5. PubMed ID: 18844837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 13-Methyl-substituted des-C,D analogs of (20S)-1alpha,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): synthesis and biological evaluation.
    Plonska-Ocypa K; Sicinski RR; Plum LA; Grzywacz P; Frelek J; Clagett-Dame M; DeLuca HF
    Bioorg Med Chem; 2009 Feb; 17(4):1747-63. PubMed ID: 19167893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D: an old prohormone with an emergent role in chronic kidney disease.
    Coen G
    J Nephrol; 2008; 21(3):313-23. PubMed ID: 18587719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of secondary hyperparathyroidism in uremic patients: the role of the new vitamin D analogs.
    Brancaccio D; Cozzolino M; Galassi A; Chiarelli G; Butti A; Bellasi A; Rocca-Rey L; Volpi A; Anelli A; Zoni U; Fusaro M; Brambilla C; Missaglia E; Crovetto C; Russo M; Longhini C; Provenzano R; Incalcaterra F; Cerasola G; Li Vecchi M; Gallieni M
    J Nephrol; 2007; 20(1):3-9. PubMed ID: 17347966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D compounds: clinical development as cancer therapy and prevention agents.
    Trump DL; Muindi J; Fakih M; Yu WD; Johnson CS
    Anticancer Res; 2006; 26(4A):2551-6. PubMed ID: 16886663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of secondary hyperparathyroidism.
    Cunningham J
    Ther Apher Dial; 2005 Aug; 9 Suppl 1():S35-40. PubMed ID: 16109140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The new low calcemic vitamin D analog 22-ene-25-oxa-vitamin D prominently ameliorates T helper cell type 1-mediated colitis in mice.
    Daniel C; Radeke HH; Sartory NA; Zahn N; Zuegel U; Steinmeyer A; Stein J
    J Pharmacol Exp Ther; 2006 Nov; 319(2):622-31. PubMed ID: 16914561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D receptor ligands for osteoporosis.
    Cheskis BJ; Freedman LP; Nagpal S
    Curr Opin Investig Drugs; 2006 Oct; 7(10):906-11. PubMed ID: 17086935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The practical synthesis of vitamin D analogs: a challenge for process research.
    Kabat MM; Radinov R
    Curr Opin Drug Discov Devel; 2001 Nov; 4(6):808-33. PubMed ID: 11899621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analogs of 1alpha,25-dihydroxyvitamin D3 with high potency in induction of osteoclastogenesis and prevention of dendritic cell differentiation: synthesis and biological evaluation of 2-substituted 19-norvitamin D analogs.
    Shimazaki M; Miyamoto Y; Yamamoto K; Yamada S; Takami M; Shinki T; Udagawa N; Shimizu M
    Bioorg Med Chem; 2006 Jul; 14(13):4645-56. PubMed ID: 16513359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.